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Molecular Dissection
of Two Distinct Actions of Melatonin
on the Suprachiasmatic Circadian Clock
Chen Liu,* David R. Weaver,* Xiaowei Jin,* with prevailing environmental conditions. The entraining
effect of melatonin appears to be mediated by directLauren P. Shearman,* Rick L. Pieschl,²
Valentin K. Gribkoff,² and Steven M. Reppert* action on the SCN, because melatonin applied to the
rodent SCN in vitro shifts the circadian rhythm of electri-*Laboratory of Developmental Chronobiology
Pediatric Service cal activity in a time-dependent manner (McArthur et
al., 1991, 1997; Starkey et al., 1995; Starkey, 1996). Sub-Massachusetts General Hospital
and Harvard Medical School stantial therapeutic applications of melatonin have been
developed around its circadian effect and include theBoston, Massachusetts 02114
²CNS Electrophysiology treatment of jet lag (Arendt et al., 1987; Petrie et al.,
1989) and some circadian-based sleep disorders (PalmBristol-Myers Squibb Pharmaceutical
Research Institute et al., 1991; Sack et al., 1991).
Melatonin appears to evoke its effects on SCN func-Wallingford, Connecticut 06492
tion through high affinity, guanine nucleotide binding
protein (G protein) receptors (Reppert and Weaver,
1995). Using the biologically active agonist 2-[125I]iodo-Summary
melatonin (125I-Mel), in vitro autoradiographic methods
have reproducibly detected melatonin receptors in theThe pineal hormone melatonin elicits two effects on
SCN of adult mice, rats, Siberian hamsters, and humansthe suprachiasmatic nuclei (SCN): acute neuronal
(Reppert et al., 1988; Siuciak et al., 1990; Weaver et al.,inhibition and phase-shifting. Melatoninevokes its bio-
1991; Roca et al., 1996). High-affinity melatonin recep-logical effects through G protein-coupled receptors.
tors are coupled to pertussis toxin-sensitive G proteinsSince the Mel1a melatonin receptor may transduce the
(Carlson et al., 1989; Morgan et al., 1990; Vanecek andmajor neurobiological actions of melatonin in mammals,
Klein, 1992).we examined whether it mediates both melatonin ef-
A recent advance in understanding the molecular ba-fects on SCN function by using mice with targeted
sis of melatonin's action has been the cloning of a familydisruption of the Mel1a receptor. The Mel1a receptor
of G protein-coupled receptors for the pineal hormoneaccounts for all detectable, high affinity melatonin
(reviewed by Reppert and Weaver, 1995). Two melatoninbinding in mouse brain. Functionally, this receptor is
receptor subtypes, the Mel1a and Mel1b melatonin recep-necessary for the acute inhibitory action of melatonin
tors, have been identified in mammals by molecularon the SCN. Melatonin-induced phase shifts, however,
cloning studies. The Mel1a receptor gene is expressedare only modestly altered in the receptor-deficient
in brain areas in which 125I-Mel binding is detected, in-mice; pertussis toxin still blocks melatonin-induced
cluding the SCN (Reppert et al., 1994; Weaver andphase shifts in Mel1a receptor-deficient mice. The other
Reppert, 1996; Roca et al., 1996). This has led to themelatonin receptor subtype, the Mel1b receptor, is
hypothesis that this receptor subtype mediates the ma-expressed in mouse SCN, implicating it in the phase-
jor neurobiological actions of melatonin in mammals,shifting response. The results provide a molecular ba-
sis for two distinct, mechanistically separable effects including those on SCN function (Reppert et al., 1994).
of melatonin on SCN physiology. Expression of the mammalian Mel1b receptor gene has
been more difficult to evaluate. Mel1b receptor mRNA has
not been detected in any brain region by conventional inIntroduction
situ hybridization methods (Reppert et al., 1995; our
unpublished data). Its expression is detectable in humanThe suprachiasmatic nuclei (SCN) are the site of a mas-
retina and brain by reverse transcription±polymeraseter clock in mammalian brain generating circadian
chain reaction (RT±PCR; Reppert et al., 1995).rhythms in physiology and behavior (reviewed by Klein
Lack of subtype-selective drugs for melatonin recep-et al., 1991). Normally, the light-dark cycle resets (en-
tors has made it impossible to critically evaluate thetrains) the SCN clock and the circadian rhythms it drives
contribution of each of the two receptor subtypes toto the 24 hr day. Entrainment ensures that circadian
melatonin effects in the SCN. We now test the hypothe-rhythms are expressed in correct relationship to each
sis that the Mel1a receptor mediates both acute neuronalother and to the 24 hr day, conferring temporal order
inhibition and the phase-shifting effects of melatonin onamong biological processes.
SCN function by using mice with targeted disruption ofMelatonin, the principal hormone of the vertebrate
the Mel1a receptor. Although the data show that the Mel1apineal gland, appears to elicit two effects on SCN func-
receptor is essential for melatonin-induced acute inhibi-tion. First, the hormone can acutely inhibit SCN neuronal
tion of SCN neuronal firing, we were surprised to findfiring (Mason and Brooks, 1988; Shibata et al., 1989;
that this receptor subtype is not essential for the phase-Stehle et al., 1989). This effect may be important for
shifting effects of melatonin in mice. These results 1)defining SCN sensitivity to phase-shifting (entraining)
substantiate the physiological significance of the acutestimuli. Second, melatonin itself can entrain mammalian
inhibitory effect of melatonin onbiological clock functioncircadian rhythms (Cassone, 1990; Lewy et al., 1992;
and 2) provide a molecular basis for two distinct effectsBenloucif and Dubocovich, 1996) and appears to act in
concert with light to hold circadian rhythms in phase of melatonin on SCN physiology.
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Figure 1. Targeted Disruption of the Mouse Mel1a Melatonin Receptor Gene
(A) The top is a schematic representation of 15 kb of the Mel1a receptor gene with exons (boxed) and relevant restriction sites depicted. The
position of the 39 probe used for Southern analysis (see [B]) is indicated. The middle shows the targeting construct, in which exon 1 has been
replaced by a cassette (PGKNeo) containing a promoter-driven neomycin resistance gene. The bottom represents the targeted allele integrated
into the genome by homologous recombination. E, EcoRV; S, SpeI.
(B) Southern blot analysis of genomic DNA from wild-type (1/1), heterozygous (1/2), and homozygous (2/2) Mel1a receptor-mutant mice.
Genomic DNA was digested with EcoRV and probed with a radiolabeled 39 probe (1 kb). The wild-type allele produces an 18 kb hybridizing
product, while the disrupted allele produces a 7 kb hybridizing product.
(C) PCR analysis of genomic DNA from wild-type, heterozygous, and homozygous mutant mice. Genomic DNA was subject to PCR using a
cocktail of primers A, B, and C (primer positions depicted in [A]). The wild-type allele (primers A±B) produces a 480 bp product, while the
disrupted allele (primers A±C) produces a 240 bp product.
Results chimeras were mated to C57BL/6 mice. Germline trans-
mission was obtained from both clones. Offspring of
heterozygous crosses were genotyped by either South-Targeted Disruption of the Mel1a Receptor
The mouse Mel1a receptor gene is composed of two ern blotting or PCR (Figure 1).
The Mel1a receptor gene mutation appears to have noexons divided by a large (.13 kb) intron (Roca et al.,
1996). Exon 1 encodes the 59 untranslated region and effect on survival. Of the first 501 pups born from breed-
ing heterozygotes, 131 (26.2%) were homozygous forthe coding region through the first cytoplasmic loop,
while exon 2 encodes the rest of the coding region and the receptor mutation. Within each of the two ES cell
lines generated, the ratio of genotypes from breedingthe 39 untranslated region. A targeting vector was con-
structed from a 15 kb genomic clone (from a 129/Sv heterozygotes did not differ from the expected Mende-
lian ratio of 1:2:1 (p . 0.05, chi-square test). Both malegenomic library) by replacing exon 1 with a cassette
containing a neomycin resistance gene under control and female homozygous mutants were fertile.
Because the Mel1a receptor is normally expressed inof the phosphoglycerate kinase 1 promoter (PGKNeo;
Figure 1); deletion of exon 1 should inactivate the Mel1a the SCN (Reppert et al., 1994; Roca et al., 1996) and
thus potentially involved in biological responses of thereceptor gene (see below). The resultant targeting vector
consists of z11.5 kb of genomic DNA 59 of the PGKNeo circadian clock, we assessed circadian function in ho-
mozygous mutants. No significant abnormalities in cir-cassette and z3.5 kb of genomic DNA at the 39 end
(Figure 1). The targeting vector was transfected into cadian function were detected in homozygous mutant
mice. The mutant mice exhibited robust circadian129/Sv J1 embryonic stem (ES) cells, and homologous
recombination was assessed by Southern blot analysis rhythms (of appropriate phase and amplitude) in wheel-
running behavior that entrained to the light-dark cyclewith probes flanking the targeted DNA (data not shown).
Two clones carrying the targeted allele were microin- (data not shown). Assessment of the period (cycle)
length of the activity rhythm in constant darknessjected into C57BL/6 mouse blastocysts, and resulting
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Figure 2. Targeted Disruption of the Mel1a
Receptor EliminatesDetectable 125I-Mel Bind-
ing from Mouse Brain
Coronal sections (15 mm) were examined for
125I-Mel binding by in vitro autoradiography.
The sections shown represent the major sites
of specific 125I-Mel binding in mouse brain; the
levels of the mid-SCN, anterior hypothalamus
(AHA), and anterior paraventricular nucleus
of the thalamus are depicted in the left col-
umn, and the levels of the pars tuberalis (PT)
and posterior paraventricular nucleus of the
thalamus (PVT) are depicted in the right col-
umn. Complete brain atlases cut at 180 mm
intervals were examined from two to three
adult mice for each genotype. Sections were
exposed to film for 19 days. 1/1, 1/2, and
2/2 denote 125I-Mel autoradiograms from
wild-type, heterozygous, and homozygous
littermates, respectively. Magnification,4.03.
showed no significant difference between homozygous These mice exhibited a very restricted pattern of 125I-
Mel binding in brain, similar to that described in othermutant mice (period length 5 23.47 6 0.10 hr; mean 6
rodents (Weaver et al., 1991). The most intense specificSEM; n 5 12) and wild types (23.49 6 0.08 hr; n 5 15 ).
binding was observed in the hypophyseal pars tuberalisIt is important to mention that neither 129/Sv or
(PT) of the pituitary (Figure 2). The SCN, paraventricularC57BL/6 mice make melatonin; these strains appear to
nucleus of the thalamus (PVT), and parabigeminal nu-have a genetic defect in pineal melatonin biosynthesis
cleus also contained a high level of specific 125I-Mel(Goto et al., 1989). Nonetheless, we show (see below)
binding (Figure 2). A moderate level of specific bindingthat wild-type mice of 129/Sv/C57BL/6 hybrid genetic
was present in the anterior hypothalamus (anterior andbackground have a normal complement of high affinity
lateral to the SCN), in several thalamic nuclei (the reun-melatonin receptors as assessedby 125I-Mel in vitro auto-
iens nucleus, the nucleus of the stria medullaris, andradiography. In addition, as described in subsequent
portions of the paratenial and anterodorsal nuclei), andsections, the SCN of these mice exhibit robust re-
in the caudal half of the nucleus of the optic tract (Figuresponses to melatonin in the two in vitro assay systems
2; data not shown). Lower levels of specific 125I-Mel bind-that we employ in our studies. Thus, we are confident
ing were detected in the medial portion of the accum-that studies of receptor and effector mechanisms in-
bens nucleus, in the central nucleus of the amygdala,volved in the SCN are valid in 129/Sv/C57BL/6 mice.
and at the lateral border of the anterior pretectal nucleus.
Low levels of specific 125I-Mel binding were detected in
Targeted Disruption of the Mel1a Receptor several (but not all) wild-type mice in the medial portion
Eliminates Detectable 125I-Mel of the nucleus of the solitary tract bordering the area
Binding in Brain postrema and in the midbrain central grey. The distribu-
To determine whether the Mel1a receptor gene is inacti- tion of 125I-Mel binding in wild-type mice is comparable
vated in homozygous mutants, 125I-Mel in vitro autoradi- to that previously reported for C57BL/6J mice and is
ography was used. This method is the most sensitive also similar to that reported for strains of mice that make
means currently available to evaluate the presence of melatonin (C3H/HeN; Siuciak et al., 1990; Roca, 1996).
high affinity melatonin receptors in individual brain nu- In marked contrast to the detection of specific 125I-Mel
clei (Weaver et al., 1991). Our prediction for these studies binding in several brain regions in wild-type mice, spe-
was that since Mel1a receptor mRNA is found in brain cific 125I-Mel binding was not detected in any of these
areas in which 125I-Mel binding is detected, targeted dis- sites in homozygous mutantmice (Figure 2). Importantly,
ruption of the Mel1a receptor would eliminate 125I-Mel by light microscopy, the SCN appeared normal in loca-
binding in mouse brain. tion and size in homozygous mutants. Visual inspection
of the autoradiographs suggested that heterozygousWe first evaluated 125I-Mel binding in wild-type mice.
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Figure 3. Paradigm for Examining Melatonin-
Induced Inhibition of Multiunit SCN Activity
in Mice
Rhythms of multiunit activity in SCN slices
were monitored for 36 hr from wild-type (1/1;
upper panel) and homozygous mutant (2/2;
lower panel) mice. The left horizontal bar
above each panel shows the time of treat-
ment (vehicle or melatonin) from circadian
time 9.5±11.5 on day 1 in culture; vehicle
treatment is depicted (black bars). The right
horizontal bar above each panel shows the
time of vehicle treatment (closed portion of
bar; CT 4.0±4.5) and melatonin treatment
(open portion of bar; CT 4.5±6.5) on day 2 in
culture. Melatonin treatments consisted of 30
min consecutive exposures to 0.1, 1, 10, and
100 nM melatonin. Note the melatonin-
induced suppression of multiunit activity from
CT 4.5±6.5 in the wild-type slice and the aboli-
tion of this suppression in the homozygous
mutant slice. The horizontal bars below each
panel depict the light-dark cycle the animals
were exposed to before killing.
mutant mice have an intermediate level of 125I-Mel bind- this is the time when melatonin has been shown to shift
the phase of the circadian rhythm in locomotor activitying (Figure 2). This was confirmed by quantitative in vitro
autoradiographic analysis of 125I-Mel binding in the SCN; in vivo (Cassone, 1990; Benloucif and Dubocovich, 1996)
as well as the rhythm in SCN firing rate in vitro (Starkeythe level of specific 125I-Mel binding in the SCN of hetero-
zygous mice (n 5 9) was 52.5% that of wild-type mice et al., 1995; McArthur et al. 1991, 1997). Because of the
large decline in firing rate between CT 9.5±11.5 (see(n 5 5; P 5 0.001, Student's t test). The z50% reduction
in binding in heterozygous animals suggests an effect Figure 3), the effects of melatonin application on firing
rate were assessed relative to a separate group of slices,of gene dosage on the level of 125I-Mel binding observed.
Preliminary studies of fetal mouse brain and pituitary to which vehicle was applied at the identical time. Mela-
tonin effects were also examined at CT 4.5±6.5 becausealso revealed that 125I-Mel binding detected in these
structures in wild-type mice was absent in homozygous the peak of the rhythm in multiunit activity occurs at this
time, and multiunit activity is constant over this period.Mel1a receptor-mutant mice and reduced in heterozy-
gotes. Taken together, the autoradiographic results Melatonin treatments at CT 4.5±6.5 were compared with
prior vehicle treatments (at CT 4.0±4.5) of the same slice.clearly show that the engineered Mel1a receptor gene
mutation is a null allele and that Mel1a receptors normally Circadian rhythms of firing rate were comparable in
phase and amplitude between wild-type and homozy-account for most, if not all, high affinity melatonin bind-
ing in mouse brain. gous mutant mice (Figure 3; data not shown).
Melatonin caused a consistent inhibition of multiunit
activity in SCN slices from wild-type mice. When melato-Targeted Disruption of the Mel1a Receptor
Abolishes the Acute Inhibitory Effect of nin was applied at increasing concentrations (0.1, 1, 10,
and 100 nM at 30 min intervals) from CT 4.5±6.5, thereMelatonin on SCN Neuronal Firing
We next examined the ability of melatonin to acutely was a significant, concentration-dependent inhibition
of neuronal activity in slices from wild-type mice com-suppress SCN neuronal firing in wild-type and Mel1a re-
ceptor-deficient mice. For this aspect of study, multiunit pared with vehicle treatment from CT 4.0±4.5 (P 5 0.001,
one-way ANOVA; Figures 3 and 4, upper panels). Therecordings of hypothalamic slices containing SCN were
used. With this system, circadian rhythms in neuronal EC50 of the melatonin-induced inhibition was 412 pM.
When melatonin (0.1±100 nM) was applied from CT 9.5±firing rate can be consistently monitored for 3 days in
culture (V. Gribkoff, unpublished data). The suppressive 11.5, there was also a significant inhibition of neuronal
activity compared to vehicle-treated slices (p , 0.05,effect of melatonin on neuronal firing was examined at
two circadian times (CT , where CT 12 is the projected one-way ANOVA; Figure 4, lower panel), but the melato-
nin effect was much more variable because of the steeptime of lights off in the colony room). Studies were con-
ducted at CT 9.5±11.5 on day 1 in culture and CT 4.5±6.5 slope of the multiunit activity pattern at this time (see
Figure 3). These results indicate that the in vitro multiuniton day 2 (Figure 3). CT 9.5±11.5 was examined because
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melatonin's ability to suppress SCN multiunit activity.
At both treatment times, CT 9.5±11.5 and CT 4.5±6.5,
melatonin (0.1±100 nM) was unable to significantly in-
hibit SCN multiunit activity in Mel1a receptor-deficient
mice, relative to vehicle treatments (p . 0.50 for each
treatment time, one-way ANOVAs; Figure 3, lower panel
and Figure 4, upper and lower panels). These results
indicate that theMel1a receptor mediates theacute inhib-
itory effect of melatonin observed with SCN multiunit
recordings.
Studies in wild-type C57BL/6 mice showed that physi-
ological levels of melatonin (1 nM) also inhibit SCN
multiunit activity at night at CT 18 (33.9% 6 3.9% inhibi-
tion; n 5 8). This is important, because it is at a time
when melatonin levels are normally high in the living
animal (Klein, 1993). Thus, melatonin can elicit its inhibi-
tory effect on SCN function at a physiologically relevant
time.
Targeted Disruption of the Mel1a Receptor
Modifies But Does Not Eliminate the
Phase Shifting Effect of Melatonin
on the SCN Firing Rhythm
The phase-shifting effects of melatonin in wild-type and
Mel1a receptor-deficient mice were assessed using an
in vitro assay, in which single-unit extracellular activity
is monitored from SCN slices. This in vitro method was
used because it is not subject to the artifactual results
sometimes observed with in vivo drug treatments (Van
Reeth and Turek, 1989; Hastings et al.,1992). In addition,
the melatonin-induced shifts in vitro are much larger
Figure 4. Targeted Disruption of the Mel1a Receptor Blocks Melato- than those produced in vivo to single or multiple injec-
nin-Induced Inhibition of Multiunit SCN Activity
tions of melatonin (Cassone, 1990; McArthur et al., 1991;
The upper panel shows the effects of melatonin treatment from CT Starkey, 1996). Moreover, studies in rats have shown
4.5±6.5 (day 2 in culture) on multiunit activity in SCN slices from
that the phase-shifting effect of melatonin on the single-wild-type (1/1) and homozygous mutant (2/2) mice. For each slice,
unit activity rhythm is a high affinity response (EC50 ,the percent inhibition of SCN firing rate induced by melatonin was
determined relative to vehicle treatment at CT 4.0±4.5. Melatonin 100 pM) and that it is blocked by pertussis toxin (Starkey
treatments consisted of 30 min consecutive exposures to 0.1, 1, 10, et al., 1995; McArthur et al., 1997). These characteristics
and 100 nM melatonin. All SCN slices were also treated with either are consistent with melatonin inducing phase shifts by
vehicle or melatonin on day 1 in culture. There was no significant
a high affinity, G protein-coupled melatonin receptor.effect of melatonin application on day 1 in culture, relative to vehicle
For our in vitro studies, the phase-shifting effect ofapplication, on the day 2 (CT 4.5±65) melatonin response data (P 5
melatonin was examined at CT 9.5±10.5, because in0.45), so the data sets were combined. This is because there is no
significant effect of melatonin treatment on day 1 to the timing of rats and in our preliminary studies of wild-type mice,
the multiunit activity peak on day 2; the broad peak of the multiunit melatonin application at this time consistently elicited
activity rhythm precludes use of this assay for monitoring melatonin- a z4 hr phase advance in circadian phase (data not
induced phase shifts. The genotype of the animals was not known shown). We also showed that melatonin application from
until after experiments were completed and data were analyzed.
CT 5.5±6.5 to SCN slices from wild-type mice did notEach value is the mean 6 SEM of 7±11 slices for each genotype at
elicit significant phase shifts in the electrical activityeach melatonin dose.
The lower panel shows the effects of melatonin treatment from CT rhythm (CT of activity peak was 6.8 6 0.3 hr; n 5 3;
9.5±11.5 on day 1 in culture. Melatonin treatments consisted of 30 compare with control treatment in Figure 5). Thus, the
min consecutive exposures to 0.1, 1, 10, and 100 nM melatonin. SCN of wild-type mice exhibit a daily sensitivity to the
Because of the large negative slope of multiunit activity at this time
phase-shifting effects of melatonin in vitro, similar to(see Figure 3), the effects of melatonin application on firing rate were
that found in rats (McArthur et al., 1997). Consequently,assessed relative to a separate group of slices for each genotype, to
the in vitro single-unit assay is a valid method for as-which vehicle was applied at the identical time. The genotype of
the animals was not known until after experiments were completed sessing molecular mechanisms involved in melatonin-
and data were analyzed. Each value is the mean 6 SEM of 7±11 induced phase shifts in wild-type and receptor-deficient
slices for each genotype at each melatonin dose. mice. It is important to note that melatonin-induced
phase shifts are not apparent with the multiunit assay,
because of the broad firing-rate peak which occurs withassay provides a reliable methodfor assessing the acute
suppressive effect of melatonin on neuronal firing in multiunit recordings (compare multiunit and single unit
activity peaks in Figures 3 and 5, respectively). SinceSCN slices.
Targeted disruption of the Mel1a receptor abolished all detectable 125I-Mel binding in the SCN is abolished in
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Figure 5. Melatonin Phase Shifts the SCN Circadian Clock in Mice
with Targeted Disruption of the Mel1a Receptor
Figure 6. The Melatonin Agonist 2-Iodomelatonin (2-I-Mel) PhaseThe upper and middle panels show single-unit electrical activity
Shifts the SCN Circadian Clock in Mice with Targeted Disruption ofrhythms in SCN slices from wild-type (1/1) and homozygous mutant
the Mel1a Receptor(2/2) mice, respectively, exposed to vehicle from CT 9.5±10.5 (open
(A) Phase-shifting effect of 10 pM or 1 nM 2-iodomelatonin on thevertical bars). The lower panel shows the firing rate rhythm of an
SCN electrical activity rhythm in wild-type (1/1) and homozygousSCN slice from a homozygous mutant mouse exposed to melatonin
mutant (2/2) mice. SCN slices were treated with either vehicle (con-(1 nM) from CT 9.5±10.5 (hatched vertical bar), which resulted in a
trol) or 2-iodomelatonin from CT 9.5±10.5, and the peak of the firingz4 hr phase advance in the firing rate rhythm. The dotted vertical
rate rhythm was assessed (in CT) on the next day. The genotype ofline represents the average time of peak electrical activity, used as
the animals was not known until after experiments were completed.a phase reference point. Data are representative of three studies
Bars represent mean 6 SEM. *, p , 0.01, Student's t test.per treatment. Arrows indicate time of slice preparation. The dark
(B) Phase-shift data in (A) replotted to depict actual phase changeperiod of the light-dark cycle in the animal room is indicated by the
(phaseadvance) from control treatment. All phase shifts were signifi-hatched horizontal bars at the top of each panel.
cant (p , 0.01, Dunnett's test).
Mel1a receptor-deficient mice, we expected that targeted that were not significantly different in magnitude be-
disruption of the Mel1a receptor would abolish the phase- tween wild types (3.6 6 0.1 hr; n 5 3) and receptor-
shifting effects of melatonin on SCN slices as monitored deficient mice (4.4 6 0.4 hr; n 5 6; p . 0.05, Student's
with the single-unit assay. t test; Figure 6).
Remarkably, however, the SCN from mice with tar- We next examined the response to a lower concentra-
geted disruption of the Mel1a receptor still exhibited ro- tion of 2-iodomelatonin, to determine whether a contri-
bust phase shifts to both melatonin and the melatonin bution of the Mel1a receptor to the phase-shifting effect
agonist, 2-iodomelatonin. Melatonin (1 nM) applied from might be evident at a lower concentration. Indeed, when
CT 9.5±10.5 to SCN slices from Mel1a receptor-deficient 10 pM 2-iodomelatonin was applied, a clear difference
mice produced a clear z4 hr phase advance in the elec- in the magnitude of the phase shift was seen between
trical activity rhythm peak, compared to control treat- wild-type and Mel1a receptor-deficient animals (Figure
ment (Figure 5). In addition, the phase-shifting effects 6). While 10 pM 2-iodomelatonin elicited significant
of 1 nM melatonin were indistinguishable between wild- phase shifts in both wild-type and Mel1a receptor null
type and null mutant mice (data not shown). 2-Iodomela- mutant mice (p , 0.01 for each genotype versus vehicle-
treated animals, Dunnett's test), the magnitude of thetonin at 1 nM also produced large (z4 hr) phase shifts
Melatonin Action on the Circadian Clock
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Figure 7. Evidence That the Mel1b Receptor Mediates Melatonin-Induced Phase Shifts in Mel1a Receptor-Deficient Mice
(A) Pertussis toxin blocks melatonin-induced phase shifts in Mel1a receptor-deficient mice. Depicted are single-unit electrical activity rhythms
in SCN slices for homozygous mutant (2/2) mice treated with 1 nM melatonin preceded by a 5 hr static preincubation with either normal
medium (upper) or pertussis toxin (1 mg/ml; lower). Data are representative of three studies per treatment. Arrows indicate time of slice
preparation. The dark period of the light-dark cycle in the animal room is indicated by the hatched horizontal bars at the top of each panel.
(B) RT±PCR analysis reveals Mel1b receptor gene expression in the SCN of homozygous receptor mutant (2/2) mice. RNA extracted from
neonatal SCN was subjected to RT±PCR using specific primers for the Mel1b melatonin receptor. PCR products were electrophoresed and
blotted onto GeneScreen. Blots were hybridized with radiolabeled oligonucleotide probes specific for a sequence of the amplified fragment
between the primers. A hybridizing band at 367 bp was detected. No hybridizing bands were detected when template was excluded from
the PCR reactions. The Mel1b receptor gene was also expressed in SCN of wild-type mice (data not shown). A similar pattern of expression
was observed in a replicate experiment.
phase shift in receptor-deficient mice (2.0 6 0.4 hr; n 5 intracellular signaling. Since the Mel1b melatonin recep-
tor signals throughGi, pertussis toxin should block mela-4) was significantly smaller than that of wild-type mice
(3.4 6 0.2 hr; n 5 5; p , 0.01, Student's t test). These tonin-induced phase shifts in Mel1a receptor-deficient
mice.results show that the Mel1a melatonin receptor is not
necessary for the phase-shifting effects of melatonin on Indeed, pertussis toxin-pretreatment blocked that
ability of melatonin to phase shift the SCN electricalthe SCN firing-rate rhythm, but the Mel1a subtype does
contribute to the response as revealed by low 2-iodo- activity rhythm in Mel1a receptor-deficient mice. In SCN
slices subjected to a 5 hr static bath of normal mediamelatonin concentrations.
before treatment, 1 nM melatonin applied at CT 9.5±10.5
still elicited a 3.2 6 0.1 hr (n 5 3) phase advance inThe Mel1b Melatonin Receptor Is Expressed
in Mouse SCN and May Participate circadian phase (Figure 7A). However, when SCN slices
were preincubated with pertussis toxin (1 mg/ml) for thein Phase-Shifting Activities
Because melatonin elicits a high affinity phase-shift re- 5 hr before the 1 nM melatonin treatment, the phase of
the firing rhythm peak was not shifted (CT of activitysponse in SCN slices from Mel1a receptor-deficient mice,
we postulate that melatonin-induced phase shifting in peak was 6.6 6 0.1 hr; n 5 3; Figure 7A); that is, it
was similar to the circadian phase of slices treated withthe Mel1a knockout mice is mediated by the other high
affinity melatonin receptor identified in mammals, the vehicle (CT of 6.9 6 0.2 hr; see Figure 6). Thus, a pertus-
sis toxin-sensitive mechanism mediates the phase-Mel1b melatonin receptor (Reppert etal., 1995). To further
explore participation of the Mel1b receptor in phase- shifting effects of melatonin in Mel1a receptor-deficient
mice.shifting activities in Mel1a receptor-deficient mice, we
examined the effects of pertussis toxin on melatonin- If theMel1b receptor is involved in phase-shifting activ-
ities, then it must be present in mouse SCN. Expressioninduced phase shifts in these receptor-deficient mice.
Pertussis toxin ADP-ribosylates the alpha subunit of Gi, of the Mel1b receptor gene was therefore examined by
RT±PCR of mRNA from punches of SCN from wild-typeGo, and Gq, rendering these G proteins incapable of
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and Mel1a receptor-deficient mice. RT±PCR was used in SCN by in situ hybridization (Karschin et al., 1994).
Moreover, two calcium-independent potassium currentsbecause Mel1b receptor transcripts in humans and rats
(a rapidly activating type of outward rectifier potassiumare expressed at levels below the limits of sensitivity of
current and a transient A-current) have been found instandard in situ hybridization methods (Reppert et al.,
all neurons examined in rat SCN (Bouskila and Dudek,1995). We have isolated and sequenced the two exons
1995). By revealing that a G protein-coupled receptorof themouse Mel1b receptor gene that encode the coding
mediates melatonin-induced inhibition of SCN neuronalregion (unpublished data; see also Weaver et al., 1996).
firing, our Mel1a receptor knockout studies define a newThis information allowed us to design PCR primers to
potential mechanism of melatonin action onSCN function.amplify cDNA across the intron splice sites in the first
We propose that the acute inhibitory effect of melato-cytoplasmic loop (Reppert et al., 1995). The RT±PCR
nin on the SCN circadian clock is of substantial physio-results showed that the Mel1b receptor is expressed in
logical significance. By inhibiting SCN neurons, melato-the SCN of null mutant mice (Figure 7B).
nin would help define neuronal sensitivity (set the gain)
to phase-shifting stimuli. Since melatonin levels in mam-
mals are elevated only at night (Klein, 1993), it is likelyDiscussion
that this is the time when the inhibitory effect occurs.
Thus, the nighttime elevation of melatonin may normallyThe results provide molecular insights into the actions
function to decrease the responsiveness of the SCN toof melatonin on the biological clock. Our studies reveal
extraneous phase-shifting stimuli (e.g., activity-inducedtwo distinct effects of melatonin on SCN physiology: an
transmitter release). Light, on the other hand, appearsacute inhibitory effect on neuronal firing and a phase-
to have a ªprivilegedº role in phase-shifting at night,shifting effect. We show that the Mel1a melatonin recep-
because light exposure at night would not only initiatetor is necessary for the acute inhibitory action, providing
glutamate neurotransmission in the SCN (Ding et al.,a solid molecular basis for a heretofore poorly defined
1994), but also acutely inhibit nighttimemelatonin levels,effect of melatonin on the biological clock (see below).
causing circulating melatonin levels to fall precipitouslyThe phase shifting effect, on the other hand, is only
(Klein, 1993). By removing the inhibitory effect of melato-modestly altered in Mel1a receptor-deficient mice. This is
nin on SCN neuronal activity, continued light exposurea striking finding and indicates that another high affinity
is actually potentiating its own effectiveness at night, atmelatonin receptor must also be involved in the phase-
a time of the circadian cycle when the circadian clockshifting response to melatonin. Below, each of the two
is most responsive to light's phase-shifting activities. Ineffects of melatonin on SCN function is addressed in
fact, there is experimental evidence supporting a rolelight of our new findings.
for melatonin in suppressing phase shifts at night. AOur results show an acute inhibitory action of melato-
preliminary study in mice shows that melatonin adminis-nin on SCN multiunit activity at physiological levels of
tration significantly attenuates thephase-delaying effectmelatonin. Most other studies that have examined mela-
of a light-pulse applied during subjective night (Dubo-tonin-induced inhibitory effects on SCN neuronal firing
covich et al., 1996); phase-advance effects of light were
have been performed with single-unit extracellular re-
not examined. Further study of the gain-setting action
cording, using either iontophoretically applied melatonin
of melatonin on SCN neurons is clearly warranted.
or pharmacological doses of melatonin added to the
A startling aspect of the work reported here is our
culture bath (Mason and Brooks, 1988; Shibata et al., finding that the Mel1a receptor is not essential for the1989; Stehle et al., 1989). In contrast, our study with phase-shifting effect of melatonin in mice. All previous
multiunit recording shows a very consistent, robust in- lines of evidence pointed directly to the Mel1a subtype
hibitory response using physiological melatonin con- as the mediator of the phase-shifting effect of melatonin.
centrations (EC50 of the response is 412 pM). An advan- Nonetheless, we now show that 1 nM concentrations of
tage of our system is that it measures an integrated either melatonin or 2-iodomelatonin elicit large phase
response from many neurons, and thus inhibitory effects shifts of similar magnitude in SCN electrical activity
of melatonin on a restricted population of SCN neurons rhythms in both wild-type and Mel1a receptor-deficient
may be more easily and consistently detected with mice. There are two alternative models that might ex-
multiunit recordings. By exploiting the multiunit assay plain these data (Figure 8). The first and most plausible
in Mel1a receptor-deficient mice, we have discovered explanation is that the Mel1a receptor normally mediates
that an acute inhibitory effect of melatonin on SCN activ- virtually all of the phase shifting effects of melatonin;
ity is mediated through the Mel1a melatonin receptor. but when the receptor is eliminated, the phase shifting-
The Mel1a receptor-mediated inhibition of neuronal effects of another receptor, which normally contributes
firing is likely due to activation of potassium channels. little to the phase-shifting response, is unmasked. A
Whole-cell voltage-clamp studies have shown that mel- second, more heretical possibility is that the Mel1a recep-
atonin can activate potassium conductances in rat SCN tor normally only mediates a small portion of the melato-
(Jiang et al., 1995). Potassium channels are activated nin signaling involved in phase shifts, and a second
by the bg subunits of pertussis toxin-sensitive Gproteins high affinity receptor primarily mediates phase-shifting
(Wickman and Clapham, 1995), consistent with Mel1a responses to melatonin. It is also possible that a low
signaling through Gi (Reppert et al., 1994). The recombi- level of either melatonin receptor is sufficient for the
nant human Mel1a receptor also activates heteromeric phase-shifting response. Regardless of which alterna-
Kir3.1/3.2 potassium channels when expressed in Xeno- tive is operable, the results show that at least two differ-
pus oocytes (Nelson et al., 1996), and expression of ent receptors can mediate the phase-shifting effect of
melatonin in the mouse SCN.Kir3.1 and Kir3.2 channel subunits has been detected
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Davis, 1993). Again, the implication is that the Mel1a re-
ceptor is the only functional receptor in the Syrian ham-
ster capable of mediating the phase-shifting response
to melatonin in the developing SCN. In contrast to ham-
sters, the mouse Mel1b receptor appears to be functional
(i.e., there are no nonsense mutations in the coding
region; unpublished data), and thus, in both mouse and
human, a functional Mel1b receptor could participate in
circadian phase-shifting activities. It is important to add
that with the substantial species differences in which
melatonin receptor genes encode functional receptors
(Mel1a receptor only or both Mel1a and Mel1b receptors),
the mouse is most like the human, making the mouse
SCN a model system that may closely mimic SCN func-
tion in humans.
If, as we propose, the Mel1b receptor is mediating
melatonin-induced phase shifts in mice with targeted
deletion of the Mel1a receptor, then the lack of detectable
125I-Mel binding means that only a minuscule number of
high affinity receptors are needed to elicit a near-maxi-
mal phase-shifting response. This lack of a correlation
between detectable 125I-Mel binding and a functional
response to melatonin is not unique to the mouse SCN.
In cerebral and tail arteries, melatonin also elicits a high
affinity response (vasoconstriction) without evidence of
125I-Mel binding in mouse vessels by conventional in vitro
autoradiography (C. Mahle, personal communication).
Only further studies in mice with targeted deletion of
the Mel1b receptor, and in mice with deletion of both the
Mel1a and Mel1b receptors, will define the actual contribu-
Figure 8. Alternative Models of Melatonin Receptor Involvement in tion of each receptor subtype to the phase-shifting
Melatonin-Induced Phase Shifts in Mouse SCN effect of melatonin in mouse SCN. Although unlikely, it
(A) The Mel1a receptor is the primary receptor mediating melatonin is also possible that the phase-shifting effect of melato-
phase shifts in SCN with a small contribution from the Mel1b receptor. nin in Mel1a receptor-deficient mice is mediated through(B) The Mel1b is the primary receptor mediating melatonin phase
a novel (yet to be cloned) high affinity, pertussis toxin-shifts in SCN with a small contribution from the Mel1a receptor.
sensitive receptor.M, melatonin.
Our results suggest that the cellular mechanisms in-
volved in the acute inhibitory and phase-shifting effects
The receptor involved in melatonin-induced phase of melatonin are distinct. Even though the acute sup-
shifting in Mel1a receptor-deficient mice appears to be pressive effect of melatonin on SCN multiunit firing at CT
a high affinity, G protein-coupled receptor. Since the 9.5±11.5 is abolished in Mel1a receptor-deficient mice,
only other high affinity melatonin receptor cloned from melatonin can still elicit large phase shifts at this time.
mammals is the Mel1b receptor, which is expressed in Thus, the acute activation of potassium channels, which
mouse SCN (Figure 7), the Mel1b subtype becomes the has been implicated in serotonin-induced phase shifts
prime candidate for the receptor mediating circadian in rat SCN (Prosser et al., 1994), appears not to be
phase shifting in Mel1a receptor-deficient mice. Curi- involved in a substantial way in the melatonin-induced
ously, the Mel1b receptor is nonfunctional in Siberian and phase-shifting mechanism in mouse SCN. Although the
Syrian hamsters (Weaver et al., 1996; our unpublished precise signal transduction cascade mediating melato-
data); in both species, there are nonsense mutations in nin-induced phase shifting in mammalian SCN has not
the region of the receptors encoded by the second exon. been clearly delineated, studies in rats have suggested
In the Siberian hamster, the Mel1a receptor is functional, the involvement of protein kinase C (McArthur et al.,
and melatonin elicits clear phase-shifting effects on the 1997) and nitric oxide (Starkey, 1996). Further elucida-
SCN electrical activity rhythm (Weaver et al., 1996). The tion of the receptors involved in melatonin-induced
implication is that the Mel1a receptor is the only func- phase shifts in mouse SCN should help clarify the intra-
tional high affinity melatonin receptor in the Siberian cellular signaling cascades important for the receptor-
hamster capable of mediating the phase-shifting re- mediated effects.
sponse. In the Syrian hamster, in vivo administration of In summary, the results present a solid molecular
melatonin entrains circadian rhythms only in fetal and basis for two distinct effects of melatonin on SCN func-
neonatal hamsters (Davis and Mannion, 1988; Grosse tion. Further elucidation of the cellular and molecular
et al., 1996), not in adults (Hastings et al, 1992). This mechanisms involved in these actions of melatonin
developmental alteration in melatonin responsiveness should provide a firm foundation for understanding how
is paralleled by a developmental decrease in 125I-Mel this hormone influences circadian function. That melato-
nin can acutely suppress SCN neuronal activity adds abinding in the SCN with increasing age (Duncan and
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amplification of the appropriate size cDNA fragment would eliminatenew cautionary note to the use of high doses of melato-
amplification of genomic DNA. The Mel1b receptor-specific primersnin in humans. Elevated levels of exogenous melatonin
were 59-CTC AGT GCT CAG GAA CCG CAA GCT-39 and 59-CCTcould ªnumbº the SCN, making it less responsive to
AGT ATG AGA TTT CTG GGG TGT-39 and amplify a band of 367
phase-shifting stimuli that normally keep our biological bp. Histone-H3.3 served as a control to verify the efficiency of the
clock in tune with the environment. RTreaction. The histone H3.3 primers were 59-GCAAGAGTGCGCCC
TCTACTG-39 and59-GGCCTCACTTGCCTCCTGCAA-39 and amplify
a band of 217 bp.Experimental Procedures
After PCR, the reaction products were subjected to electrophore-
sis through a 1.5% agarose gel and blotted onto GeneScreen (NewConstruction of the Mel1a Receptor Targeting Vector
England Nuclear). Blots were hybridized with 25-mer oligonucleo-A 15 kb genomic clone encoding part of the Mel1a receptor was
tides, labeled with [g-32P]ATP by T4 polynucleotide kinase. For eachisolated from a mouse 129/Sv genomic library (Stratagene) using a
primer pair, the oligonucleotide probes were specific for a sequenceprobe generated from exon 1. The genomic clone contains z11.5
of the amplified fragment between the primers. Oligonucleotide se-kb 59 of exon 1, exon 1 (0.6 kb, containing the translation start codon
quences were 59-TCATAGTACCACCTACCACCGGGTC-39 for theand encoding amino acids up to the first intracellular loop), and
Mel1b receptor; and 59-CACTGAACTTCTGATCCGCAAGCTC-39 forz3.5 kb of the large intron that separates the two exons (see Figure
histone H3.3. Hybridizing conditions were 458C overnight in 0.5 M1). The entire genomic clone was subcloned into the NotI site of
NaPO4 (pH 7.2), 7% SDS, 1% BSA, and 1 mM EDTA. The blots werepBluescript (Stratagene). The first exon was subsequently removed
washed twice in 0.2 M NaP04, 1% SDS, and 1 mM EDTA at 458Cby restriction digestion with StuI and Eco47III. SalI adapters were
for 30 min.ligated to the blunt ends to allow PGKNeo (digested with XhoI-SalI)
to be inserted in place of receptor exon 1. The 15 kb insert of the
targeting vector, containing PGKNeo, was then excised from the 125I-Mel In Vitro Autoradiography
plasmid with NotI and used for electroporation of J1 ES cells as Male mice were housed in ventilated environmental compartments
previously described (Li et al., 1992). Of 220 G418-resistant ES with a light:dark (LD) schedule of 12:12. Animals were killed by
clones isolated, 27 contain the targeted allele based on Southern decapitation in the afternoon, 3±5 hr before lights-off, at 4±7 weeks
blots of genomic DNA, digested with either EcoRV or SpeI and of age. Brains were removed, frozen in cooled (2208C) 2-methyl-
probed with a 39 flanking probe not contained within the genomic butane, and stored at 2808C until sectioning in a Bright-Hacker
clone. cryostat.
Fifteen micron coronal sections were collected as a 1-in-8 series
Generation of Mel1a Receptor-Deficient Mice throughout the entire brain from three wild-type, two heterozygous,
Two targeted ES clones (25 and 68) were injected into C57BL/6 and two homozygous mutant mice. Sections encompassing the
blastocysts as described (Bradley, 1987) to generate chimeras. Chi- hypothalamus were collected from an additional one wild-type, eight
meric males were bred to C57BL/6 females, and germline transmis- heterozygous, and three homozygous mutant mice. All tissue sec-
sion of the mutant allele was detected by Southern blot analysis or tions were processed for 125I-Mel binding in a single run. One series
PCR (see Figure 1) of tail DNA (prepared as described by Laird et (sections at 120 mm intervals) from each animal was processed for
al., 1991) from F1 offspring with agouti coat color (representing total 125I-Mel binding (100 pM 125I-Mel), and an adjacent series of
germline transmission of the ES genome). Germline transmission sections was processed for nonspecific binding (100 pM 125I-Mel in
was obtained from both clones. Offspring of heterozygous crosses the presence of 1 mM melatonin). The ligand concentration of 100
were genotyped by Southern blotting or PCR (Figure 1). pM was used to improve the chances of detection of binding to the
Mel1b receptor, which may have a lower affinity (KD 5 160 pM for
the human clone). The autoradiographic procedure was exactly asGenotyping by Southern Blot Analysis
previously described (Reppert et al., 1994). Briefly, sections wereGenomic DNA was digested with either EcoRV or SpeI and sepa-
preincubated in autoradiography buffer (50 mM Tris-HCl and 4 mMrated by electrophoresis through a 0.8% agarose gel. DNA was
MgCl2, containing 0.1% BSA) for 1 hr at roomtemperature, incubatedalkaline denatured and transferred to GeneScreen plus membrane
in buffer with 100 pM 125I-Mel (6 1 mM melatonin), washed in ice-(Dupont/NEN) by capillary action. Membranes were hybridized with
cold autoradiography buffer minus BSA (2 times for 15 min), dippeda PCR-generated 1.0 kb DNA fragment 39 of the targeted DNA (see
in ice-cold distilled water, and then blown dry with a stream of coolFigure 1) labeled with [a-32P]dCTP (2000 Ci/mmol) by random prim-
air. Sections were apposed to Kodak BioMax MR film for 19 days.ing. Blots were washed with 0.23 SSC and 0.1% SDS at 658C.
Quantitative analysis of autoradiograms was performed using a
computer-based image analysis system and the NIH Image pro-Genotyping by PCR Analysis
gram. Radioactivity levels were determined by comparison to 125I-Genomic DNA was subjected to 35 cycles of amplification using
microscale standards (Amersham) exposed along with the sectionsincubations at 948C for 45 s, 608C for 45 s, and 728C for 3 min. The
on each film.amplified DNA was separated on an agarose gel. The primers used
for genotyping (position of primers shown in Figure 1) were: (A)
59-GAGTCCAAGTTGCTGGGCAGTGGA-39, (B) 59-GAAGTTTTCTCA SCN Multiunit Recordings
GTGTCCCGCAATGG-39, and (C) 59-CCAGCTCATTCCTCCACTCAT Adult male wild-type and homozygous mutant mice were housed
GATCTA-39. in LD 12:12 for a minimum of 3 weeks prior to experimentation. After
the adaptation period, the mice were killed 2.0±4.5 hr after lights-
on, and brains were rapidly dissected and placed into ACSF mediumRT±PCR Analysis
An RT±PCR assay was performed using a modification of a pre- containing (in mM) NaCl (116.3), KCl (5.4), NaH2PO4 (1.0), NaHCO3
(26.2), CaCl2 (1.8), MgSO4 (0.8), dextrose (24.6), and 5 mg/l Gentami-viously described procedure (Kelly et al., 1993). SCN were obtained
from 1-week-old mice. Cylindrical punches of unilateral SCN were cin sulphate (pH 7.5).
A block of tissue containing the hypothalamus was dissectedmade from 400 mm coronal sections, using a 20 gauge needle. Total
RNA was extracted from a batch of SCN punches from the same from the brain and transferred to a manual tissue chopper, where
coronal hypothalamic brain slices (400 mm in thickness) containinggenotype (four to nine animals per batch) using an Ultraspec RNA
Isolation System (Biotecx Labs). Total RNA (z2 mg) from SCN of the SCN were prepared. Slices were placed in a Haas-type brain
slice chamber (Haas et al., 1979; Medical Systems Corporation),wild-type or homozygous mutant mice was primed with random
hexamers and reverse transcribed as previously described (Reppert and gauze strips were placed over the slices in the vicinity of the
SCN to raise the fluid level above the slices. They were continuallyet al., 1994). The cDNA was subjected to 25 cycles of amplification
with 200 nM each of two specific primers. PCR conditions were superfused with ACSF medium warmed to 378C.
To record multiple-unit SCN electrical activity, a 76 mm diameter,948C for 45 s, 608C for 45 s, and 728C for 2 min. The Mel1b receptor-
specific primers were designed to amplify cDNA across the intron teflon-coated, platinum-iridium wire electrode was lowered into the
brain slice in the SCN (Bouskila and Dudek, 1993). This electricalsplice sites in the first cytoplasmic loop. Since the intron is z9 kb,
Melatonin Action on the Circadian Clock
101
activity was amplified, and the number of electrical events was Benloucif, S., and Dubocovich, M.L. (1996). Melatonin and light in-
duce phase shifts of circadian rhythms in the C3H/HeN mouse. J.counted with a window discriminator (Fintronics, Incorporated).
Data were collected and analyzed by computer using Brainwave Biol. Rhythms 11, 113±125.
(Data Waver Technologies)or Spike2 (CambridgeElectronic Design) Bouskila, Y., and Dudek, F.E. (1993). Neuronal synchronization with-
software. The average number of electrical events in successive 1 out calcium-dependent synaptic transmission in the hypothalamus.
min intervals was determined and plotted against the circadian time Proc. Natl. Acad. Sci. USA 90, 3207±3210.
of recording. Slices were excluded if their viability was compromised Bouskila, Y., and Dudek, F.E. (1995). A rapidly activating type of
on day 2 of recording. outward rectifier K1 current and A-current in rat suprachiasmatic
Melatonin was prepared as a 100 mM stock solution in 100% nucleus neurones. J. Physiol. 488, 339±350.
ethanol, which was serially diluted with ACSF to yield 4 melatonin
Bradley, A. (1987). Production and analysis of chimaeric mice. Inconcentrations between 0.1 and 100 nM. A stock solution or vehicle
Teratocarcinomas and Embryonic Stem Cells, E.J. Robertson, ed.(100% ethanol) was serially diluted with ACSF to yield the corre-
(Oxford: IRL Press), pp. 113±151.sponding vehicle for each melatonin concentration. Melatonin or
Carlson, L.L., Weaver, D.R., and Reppert, S.M. (1989). Melatoninvehicle was applied by gravity flow in the bath for 30 min at each
signal transduction in hamster brain: inhibition of adenylyl cyclaseconcentration before switching to the next solution. In preliminary
by a pertussis toxin-sensitive G protein. Endocrinology 125, 2670±experiments, we found that 30 min melatonin application was suffi-
2676.cient to produce maximal inhibition of firing in SCN slices from
rats. In the mouse experiments at CT 4.5±6.5, where only the single Cassone, V.M. (1990). Effects of melatonin on vertebrate circadian
highest vehicle concentration was used as a comparator, the vehicle systems. Trends Neurosci. 13, 457±464.
was applied for 30 min prior to the application of melatonin. A Davis, F.C., and Mannion, J. (1988). Entrainment of hamster pup
programmable automatic solution switching system (AutoMate Sci- circadian rhythms by prenatal melatonin injections to the mother.
entific, Incorporated) was employed to time solution applications. Am. J. Physiol. 255, R439±R448.
There were no significant effects of vehicle observed in any of the
Ding, J.M., Chen, D., Weber, E.T., Faiman, L.E., Rea, M.A., andexperiments.
Gillette, M.U. (1994). Resetting the biological clock: mediation ofThe maximum % inhibition of SCN neuronal firing during each 30
nocturnal circadian shifts by glutamate and NO. Science 266, 1713±min application of melatonin or vehicle was calculated with respect
1717.to the average multiunit firing rate, during the 5 min period prior to
Dubocovich, M.L., Benloucif, S., and Masana, M.I. (1996). Melatoninthe first application of a series, and plotted.
receptors in the mammalian suprachiasmatic nucleus. Behav. Brain
Res. 73, 141±147.
SCN Single Unit Recordings
Duncan, M.J., and Davis, F.C. (1993). Developmental appearanceMice were housed in LD 12:12 for 3 weeks prior to experimentation.
and age related changes in specific 2-[125I]iodomelatonin bindingAfter adaptation, mice were killed by decapitation during the light
sites in the suprachiasmatic nuclei of female Syrian hamsters. Brainphase of the LD cycle. Hypothalamic slices (500 mm) were prepared
Res. Dev. Brain Res. 73, 205±212.using a tissue chopper and incubated at 378C, as previously de-
Goto, M., Oshima, I., Tomita, T., and Ebihara, S. (1989). Melatoninscribed (Liu and Gillette, 1996). For most experiments, perfusion
content of the pineal gland in different mouse strains. J. Pineal Res.was discontinued during the 1 hr treatment with melatonin or vehicle
7, 195±204.(0.0001% ethanol in perfusion medium). For the pertussis toxin ex-
periment, perfusion was discontinued for 6 hr, ending after the vehi- Grosse, J., Velickovic, A., and Davis, F.C. (1996). Entrainment of
cle or melatonin treatment. At the end of treatment, the medium Syrian hamster circadian activity rhythms by neonatal melatonin
in the chamber was replaced, and perfusion was resumed with injections. Am. J. Physiol. 270, R533±R540.
melatonin-free medium. Single units from the SCN were recorded Haas, H.L., Shaerer, B., and Vosmansky, M. (1979). A simple perfu-
the following day with glass microelectrodes (Liu and Gillette, 1996). sion chamber for the study of nervous tissue slices in vitro. J. Neu-
Signals were amplified, filtered to a band width of 0.3±3 kHz, and rosci. Methods 1, 323±325.
stored (MacADIO II, GW Instruments). Voltage pulses exceeding
Hastings, M.H., Mead, S.S., Vindacheruvu, R.R., Ebling, F.J.P., May-preset recording threshold were detected on-line by custom soft-
wood, E.S., and Grosse, J. (1992). Non-photic phase shifting of theware. Off-line analysis assigned a cluster of spikes of similar ampli-
circadian activity rhythm of Syrian hamsters: the relative potencytude and width to each unit recorded (Meister et al., 1994). Firing
of arousal and melatonin. Brain Res. 591, 20±26.rate data were analyzed as previously described to determine the
Jiang, Z.-G., Nelson, C.S., and Allen, C.N. (1995). Melatonin activatestime of peak in the activity rhythm (Liu and Gillette, 1996).
an outward current and inhibits Ih in rat suprachiasmatic nucleus
neurons. Brain Res. 687, 125±132.
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